Boditech Med Inc.

KOSDAQ:A206640 Stock Report

Market Cap: ₩339.3b

Boditech Med Past Earnings Performance

Past criteria checks 4/6

Boditech Med has been growing earnings at an average annual rate of 1.9%, while the Medical Equipment industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 6.9% per year. Boditech Med's return on equity is 12.3%, and it has net margins of 19.2%.

Key information

1.9%

Earnings growth rate

2.9%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate6.9%
Return on equity12.3%
Net Margin19.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Oct 14
Risks Still Elevated At These Prices As Boditech Med Inc. (KOSDAQ:206640) Shares Dive 26%

Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Oct 11
Boditech Med (KOSDAQ:206640) Has More To Do To Multiply In Value Going Forward

Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Sep 13
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?

Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Jul 12
Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking

Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Apr 16
Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth

Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Apr 13
Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today

Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Mar 01
Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?

Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Jan 18
Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly

Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Dec 28
Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock

Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Dec 08
Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?

Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 18
Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Revenue & Expenses Breakdown

How Boditech Med makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A206640 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24141,86327,30035,38915,256
30 Jun 24139,13430,43834,20914,415
31 Mar 24137,83927,04534,88613,754
31 Dec 23134,21925,94733,64213,410
30 Sep 23128,15525,87130,33412,766
30 Jun 23121,04122,60929,47012,730
31 Mar 23110,21821,11726,54914,110
31 Dec 22118,07724,15227,00914,676
30 Sep 22126,06625,04131,49315,938
30 Jun 22142,18733,34031,20415,944
31 Mar 22159,95341,45731,28715,330
31 Dec 21157,70844,36728,86614,258
30 Sep 21177,61656,04823,87613,045
30 Jun 21174,33456,01821,46912,837
31 Mar 21163,62554,38919,61112,114
31 Dec 20144,13145,48917,39811,585
30 Sep 20106,46331,27415,18510,426
30 Jun 2084,71221,26714,9189,507
31 Mar 2070,14011,34214,6128,879
31 Dec 1972,79911,65015,0388,543
30 Sep 1971,9034,04815,5328,647
30 Jun 1971,81577216,0278,847
31 Mar 1970,81085316,2938,805
31 Dec 1866,204-1,69115,8389,102
30 Sep 1862,113-3,51015,88810,758
30 Jun 1855,175-4,20615,26311,041
31 Mar 1852,908-3,88015,47510,707
31 Dec 1752,594-2,14815,3899,933
30 Sep 1752,7036,40015,2418,000
30 Jun 1755,8329,62714,5957,805
31 Mar 1758,21111,57514,2547,559
31 Dec 1654,97412,62113,0457,602
30 Sep 1650,9117,42711,2717,145
30 Jun 1647,0532558,4677,856
31 Mar 1641,915-5898,2146,206
31 Dec 1539,821-1,9707,7425,691
31 Dec 1322,9565,4124,4343,212

Quality Earnings: A206640 has high quality earnings.

Growing Profit Margin: A206640's current net profit margins (19.2%) are lower than last year (20.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A206640's earnings have grown by 1.9% per year over the past 5 years.

Accelerating Growth: A206640's earnings growth over the past year (5.5%) exceeds its 5-year average (1.9% per year).

Earnings vs Industry: A206640 earnings growth over the past year (5.5%) exceeded the Medical Equipment industry -16.5%.

Return on Equity

High ROE: A206640's Return on Equity (12.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 07:02
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boditech Med Inc. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.
Changhee WooIBK Securities Co. Ltd.
JooYong KimKiwoom Securities Co., Ltd.